CD274 and head and neck squamous cell carcinoma: As such, there has not yet been a clinical trial performed investigating responses to anti-PD-1, anti-PD-L1, or anti-CTLA-4 antibody immunotherapy, with or without radiotherapy, in canine OSCC, so comparisons of response with human OSCC or HNSCC are not possible at this time.